Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial
about
Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy, safety and populatio ...... e, randomized phase IIIb trial
@en
Efficacy, safety and populatio ...... , randomized phase IIIb trial.
@nl
type
label
Efficacy, safety and populatio ...... e, randomized phase IIIb trial
@en
Efficacy, safety and populatio ...... , randomized phase IIIb trial.
@nl
prefLabel
Efficacy, safety and populatio ...... e, randomized phase IIIb trial
@en
Efficacy, safety and populatio ...... , randomized phase IIIb trial.
@nl
P2093
P2860
P1476
Efficacy, safety and populatio ...... e, randomized phase IIIb trial
@en
P2093
Alain Munafo
Alberto Burlina
Amelie S Lotz-Havla
Ania C Muntau
Corinne De Laet
Daniela Rogoff
Diane R Mould
Flavie Moreau-Stucker
Frank Rutsch
François Eyskens
P2860
P2888
P356
10.1186/S13023-017-0600-X
P577
2017-03-09T00:00:00Z
P6179
1084251815